[Review on the etiology and treatment of bacterial pneumonias]

Nina Hrabac1, Sarija Agić, Sead Jazić

  • 1Opća bolnica Sarajevo, Bosna i Hercegovina.

Medicinski Arhiv
|April 13, 2005
PubMed

Insights

Bacterial pneumonia is a major global health concern. This review identified common bacteria causing pneumonia in Sarajevo, highlighting effective empirical treatments and preventive strategies for at-risk populations.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Context:

  • Bacterial pneumonias are a significant cause of global morbidity and mortality.
  • Community-acquired bacterial pneumonia accounts for 60-80% of pneumonia cases.
  • The United States ranks sixth globally in pneumonia-related mortality.

Purpose:

  • To review the etiology, verification, and treatment of bacterial pneumonias.
  • To analyze sputum antibiogram findings over a 17-month period.
  • To identify common bacterial pathogens and assess treatment outcomes in a hospital setting.

Summary:

  • A 17-month study (Jan 2002-May 2003) at General Hospital "Sarajevo" examined 105 sputum samples for antibiograms, revealing positive bacterial findings in 12 cases (11.4%).
  • Gram-negative bacteria (58.3%) were more prevalent than Gram-positive bacteria (41.7%). Key isolates included E. coli, Kl. Pneumoniae, and Ps. aeruginosis.
  • The majority of patients were in risk groups: over 50 years old (78.6%), with chronic obstructive lung disease (35.7%), or malignant disease (7.1%).
  • Empirical treatment with third-generation cephalosporins or ampicillin/gentamicin combinations was effective, with all patients recovering or improving.
  • Preventive measures include pneumococcus and influenza vaccines, crucial for reducing bacterial superinfections in at-risk individuals.

Impact:

  • Provides insights into the microbiological landscape of community-acquired pneumonia in Sarajevo.
  • Informs empirical treatment strategies for severe pneumonia cases.
  • Emphasizes the importance of vaccination in preventing bacterial pneumonia and superinfections in vulnerable populations.

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps: